We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FDX icon
526
FedEx
FDX
$73.4B
$2.34M 0.02%
13,508
-41
-0.3% -$6.81K
ZS icon
527
Zscaler
ZS
$24.8B
$2.33M 0.02%
20,792
-7,551
-27% -$1.03M
HDB icon
528
HDFC Bank
HDB
$123B
$2.33M 0.02%
+68,000
New +$2.21M
EPAM icon
529
EPAM Systems
EPAM
$5.51B
$2.32M 0.02%
7,084
-1,198
-14% -$407K
STZ icon
530
Constellation Brands
STZ
$22.6B
$2.31M 0.02%
9,975
-1,039
-9% -$249K
YUM icon
531
Yum! Brands
YUM
$42B
$2.29M 0.02%
17,916
+3,724
+26% +$451K
RARE icon
532
Ultragenyx Pharmaceutical
RARE
$2.52B
$2.29M 0.02%
49,480
– –
TTE icon
533
TotalEnergies
TTE
$192B
$2.29M 0.02%
36,831
+1,580
+4% +$90.2K
MAS icon
534
Masco
MAS
$14.7B
$2.28M 0.02%
48,920
-134,511
-73% -$6.48M
CF icon
535
CF Industries
CF
$19.5B
$2.28M 0.02%
26,716
+9,326
+54% +$947K
SKX
536
DELISTED
Skechers
SKX
$2.25M 0.02%
53,649
-27,462
-34% -$1.05M
ACHC icon
537
Acadia Healthcare
ACHC
$2.57B
$2.23M 0.02%
27,124
+4,694
+21% +$387K
EXR icon
538
Extra Space Storage
EXR
$33B
$2.23M 0.02%
15,130
-3,339
-18% -$534K
NTRA icon
539
Natera
NTRA
$36.3B
$2.21M 0.01%
55,000
+10,000
+22% +$412K
MKL icon
540
Markel Group
MKL
$25.4B
$2.2M 0.01%
1,671
-3,716
-69% -$4.6M
MOS icon
541
The Mosaic Company
MOS
$7.11B
$2.17M 0.01%
49,379
-25,277
-34% -$1.25M
SFM icon
542
Sprouts Farmers Market
SFM
$7.51B
$2.16M 0.01%
66,784
+11,380
+21% +$354K
LHCG
543
DELISTED
LHC Group LLC
LHCG
$2.15M 0.01%
13,320
– –
CINC
544
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$2.15M 0.01%
175,000
+130,000
+289% +$3.1M
TWLO icon
545
Twilio
TWLO
$28.6B
$2.15M 0.01%
43,838
+26,444
+152% +$1.51M
CPB icon
546
Campbell Soup
CPB
$6.84B
$2.11M 0.01%
37,243
-6,097
-14% -$320K
DVN icon
547
Devon Energy
DVN
$51B
$2.11M 0.01%
34,276
-17,826
-34% -$1.22M
SWK icon
548
Stanley Black & Decker
SWK
$14.3B
$2.1M 0.01%
27,941
-2,928
-9% -$229K
BKR icon
549
Baker Hughes
BKR
$59.6B
$2.08M 0.01%
70,574
+3,958
+6% +$109K
LI icon
550
Li Auto
LI
$14.4B
$2.04M 0.01%
100,000
+10,000
+11% +$190K
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.